Article info

Download PDFPDF
Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy
  1. Correspondence to:
    Dr C-K Hui
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Rd, Hong Kong SAR, China; ckhui23gmail.com
View Full Text

Citation

Hui C, Cheung WWW, Au W, et al
Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy

Publication history

  • Accepted June 8, 2005
  • Revised May 23, 2005
  • First published July 6, 2005.
Online issue publication 
April 18, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.